News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
235 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (15)
2 (202)
3 (277)
4 (157)
5 (4)
6 (20)
7 (338)
8 (259)
9 (169)
10 (136)
11 (69)
12 (2)
13 (5)
14 (180)
15 (278)
16 (196)
17 (214)
18 (92)
19 (3)
20 (8)
21 (80)
22 (246)
23 (224)
24 (214)
25 (91)
26 (1)
27 (5)
28 (191)
29 (236)
30 (198)
31 (235)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Essity: Year-end Report 2018
Summary of the full year and fourth quarter of 2018
January 31, 2019
·
6 min read
Policy
Inotrem Announces an Extension of Its License Agreement for the Biomarker Soluble TREM-1 to Cardiovascular Diseases
Inotrem S.A. announced the signature of an exclusive license agreement with four major research organizations, under which it receives the exclusive worldwide rights for the biomarker soluble TREM-1 in cardiovascular diseases, and in particular acute myocardial infarction.
January 31, 2019
·
2 min read
Finnish AI Software Improves Cancer Patient Care
Helsinki-based MVision developed AI software focusing on radiation treatment planning.
January 31, 2019
·
4 min read
Deals
Nordic Nanovector ASA - Allocation of PSUs - January 31, 2019
The Board of Directors of Nordic Nanovector ASA has on 31 January 2019 decided to grant 259,000 Performance Share Units to employees in accordance with the authorisation granted at the Annual General Meeting held on 30 May 2018.
January 31, 2019
·
3 min read
BioCapital
USP Announces Generics Access Plan
Quality standards can help increase the number of generic medicines available to patients
January 31, 2019
·
3 min read
Policy
Innovus Pharma Announces the Approval and Launch of its OTC Hemorrhoid Xyralid® Suppositories in Canada
Xyralid®, Suppositories for the Reduction of Swelling and Inflammation of Hemorrhoidal Tissues, is the Ninth Innovus Pharma Product launched in Canada to Date
January 31, 2019
·
4 min read
Business
Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases
The Janssen Pharmaceutical Companies of Johnson & Johnson announced a worldwide collaboration and license agreement with MeiraGTx Holdings plc.
January 31, 2019
·
5 min read
Business
DowDuPont Reports Fourth Quarter and Full Year 2018 Results
Fourth Quarter Financial Highlights
January 31, 2019
·
51 min read
Business
Dadi Announces Launch With At-Home Fertility Test and Sperm Storage Kit Making Male Reproductive Health More Accessible
The company announces just under $2 million in funding to help men start healthy families in the future from the comfort of their own home
January 31, 2019
·
3 min read
Deals
Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH, Expanding Global Footprint of its Cell and Gene Therapy Contract Development and Manufacturing Services
apceth Biopharma manufactures cell and gene therapy products for American and European clients through two manufacturing sites in Munich, Germany, certified for GMP manufacture since 2010
January 31, 2019
·
3 min read
Previous
3 of 24
Next